10-QPeriod: Q3 FY2025

CHURCH & DWIGHT CO INC /DE/ Quarterly Report for Q3 Ended Sep 30, 2025

Filed October 31, 2025For Securities:CHD

Summary

Church & Dwight Co., Inc. (CHD) reported solid top-line growth in the third quarter of fiscal year 2025, with net sales increasing by 5.0% year-over-year to $1.586 billion. This growth was driven by a 4.0% increase in product volumes across all segments, alongside a strategic acquisition and positive performance in key brands like ARM & HAMMER®, OXICLEAN®, THERABREATH®, and HERO®. Despite the revenue increase, gross margin experienced a slight compression of 10 basis points due to higher manufacturing costs, partially offset by productivity programs and benefits from the recent Touchland acquisition. The company also navigated increased marketing and SG&A expenses, partly reflecting investments in brand growth and integration costs. Significant charges from prior periods related to VMS impairments were absent this quarter, contributing to a substantial improvement in operating income and a shift to a profit of $0.75 per diluted share from a loss of $0.31 in the prior year's comparable quarter. The company's liquidity remains strong, supported by operating cash flows and an undrawn credit facility, though significant share repurchases were undertaken during the period.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased by 5.0% to $1.586 billion in Q3 2025, driven by a 4.0% increase in product volumes across all segments.
  • 2Gross margin slightly declined by 10 basis points to 45.1% due to higher manufacturing costs, but was partially offset by productivity gains and the Touchland acquisition.
  • 3Operating income significantly improved, turning positive at $254.6 million compared to a loss of $91.5 million in Q3 2024, largely due to the absence of prior-year VMS impairment charges.
  • 4Diluted EPS swung to $0.75 in Q3 2025, a substantial improvement from a loss of $0.31 in Q3 2024.
  • 5The company completed the acquisition of Touchland for $656.4 million, expected to contribute to net sales growth.
  • 6Significant share repurchases were undertaken, with $600.0 million in accelerated share repurchases and open market purchases during the nine-month period.
  • 7Liquidity remains robust, with $305.3 million in cash and cash equivalents and approximately $1.99 billion available through its credit facility and commercial paper program.

Frequently Asked Questions

Net sales increased by 5.0% to $1.586 billion, primarily driven by a 4.0% increase in product volumes across all three segments (Consumer Domestic, Consumer International, and Specialty Products Division). The acquisition of Touchland also contributed to the sales growth.

The significant VMS (Vitamins, Minerals, and Supplements) tradename and other asset impairment charges of $357.1 million recorded in the third quarter of 2024 are absent in the current quarter. This absence contributed significantly to the substantial improvement in operating income and net income per share for the three months ended September 30, 2025, compared to the prior year period.

The company is experiencing higher manufacturing costs due to labor, commodities, and tariffs. These are being partially offset by productivity programs, benefits from the Touchland Acquisition, and strategic actions to mitigate tariff impacts. The company is also focused on inventory management to reduce working capital requirements.

The company maintains a strong liquidity position with $305.3 million in cash and cash equivalents and approximately $1.99 billion in availability through its revolving credit facility and commercial paper program. Long-term debt remains stable at $2.205 billion, and the company recently entered into a new, larger unsecured revolving credit agreement.